Fiksirovannaya kombinatsiya ingibitoraangiotenzinprevrashchayushchego fermentai antagonista kal'tsiya v lecheniibol'nykh arterial'noy gipertenziey

Authors: Chazova IE¹, Ratova LG¹, Nedogoda SV¹, Lopatin Y.M¹, Perepech NB¹, Tsoma VV¹
Affiliations:
Issue: Vol 8, No 3 (2011)
Pages: 21-25
Section: Articles
URL: https://journals.eco-vector.com/2075-082X/article/view/33104
DOI: https://doi.org/10.26442/SG33104
ID: 33104

Cite item

Full Text

Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии. 2010; 3: 3-25.
Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of coronary heart disease: the Framingham study. Dis Chest 1969; 56 (1): 43-52.
Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989; 13 (Suppl. 5): I2.
Lewington S, Clarke R, Qizilbash N et al. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349): 1903-13.
Miura K, Daviglus ML, Dyer AR et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med 2001; 161 (12): 1501-8.
Coldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonists, compared with hydrochlorthiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibirors for the treatment of systemic hypertension. Am J Cardiol 1995; 75: 793-5.

Supplementary Files

Action

1. JATS XML